Acelity said today it inked a deal to acquire advanced wound care and dermatology company Crawford Healthcare for an undisclosed amount. San Antonio, Texas-based Acelity said that the acquisition of Crawford will expand its advanced wound dressing product portfolio and strengthen its position in the advanced wound care market worldwide. Crawford Healthcare produces the KerraMax […]
Acelity to layoff 68 San Antonio employees
Wound care company Acelity is set to lay off 68 employees in San Antonio, Texas, according to a report from the San Antonio Express-News. The employees are slated to be released from their positions on May 8, according to a Workforce Adjustment and Retraining Notification Act notice from the Texas Workforce Commission posted this week. […]
Acelity touts lowered complications, narcotic use in Prevena NPWT cesarean trial
Acelity today released results from a study of cesarean procedures for obese patients, touting a reduction in post-surgical wound complications and narcotic use for patients who underwent closed incision negative pressure wound therapy using its Prevena incision management system. Results from the study were published in the American Journal of Perinatology. “Cesarean deliveries are the most […]
Halyard Health taps former Acelity head Woody for CEO | Personnel Moves July 5, 2017
Halyard Health (NYSE:HYH) said late last month it tapped former Acelity prez & CEO Joseph Woody as its new chief executive officer, replacing a retiring Robert Abernathy. Woody will also assume a seat on the board of directors, with former CEO Abernathy continuing on as board chair, the Alpharetta, Ga.-based company said. “On behalf of the […]
Acelity taps Jokinen as CFO, exec VP | Personnel Moves June 20, 2017
Acelity said last week it tapped Tracy Jokinen as its chief financial officer and executive vice president, taking over for interim CFO Todd Wyatt. Jokinen was formerly a CFO of uniform and facility services provider G&K services, which was acquired by Cintas earlier this year. Prior to working at G&K, Jokinen spent more than 20 years at […]
Acelity launches Prevena Duo NPWT system in US
Acelity said today it launched its Prevena Duo incision management system in the US. The Prevena Duo is a single use negative pressure wound therapy system specifically designed for the simultaneous management of 2 closed surgical incisions, the San Antonio, Texas-based company said, claiming it is the 1st such product of it’s kind. The system is designed […]
7 medtech stories we missed this week: April 14, 2017
From FDA approvals to business expansion plans, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. BioTelemetry launches offer to acquire LifeWatch BioTelemetry and LifeWatch announced in an April 9 press release that the 2 companies have entered a transaction agreement that states BioTelemetry will launch a tender offer […]
Acelity pays down debt with LifeCell proceeds, snags new $1.1B facility
Acelity said today it used proceeds from the sale of its LifeCell regenerative medicine to repay debt owed by the company and its subsidiaries Kinetic Concepts and KCI USA. The San Antonio, Texas-based company said it repaid in full the existing credit facilities of its Kinetic Concepts and KCI USA subsidiaries and redeemed all outstanding […]
Allergan closes $3B Acelity LifeCell buy
Acelity said today that it closed the sale of its regenerative medicine unit, LifeCell, to Allergan (NYSE:AGN) for $2.9 billion in cash. The deal brings LifeCell’s regenerative medicine and reconstructive portfolio to Allergan, joining a portfolio of medical aesthetics, breast implant and tissue expander product lines. Dublin-based Allergan said it expects to bring in $450 million in revenue this year, growing […]
How Acelity plans to disrupt fee-for-service to build a value-based business
Value-based care is disrupting the old fee-for-service models in the U.S. healthcare industry, and medical device makers must adapt or perish. Here’s how wound care company Acelity is responding. The rise of value-based care in the U.S. is causing a major shift in the medical device industry. Health provider customers want to know how medical […]
Allergan picks up Acelity’s LifeCell biz for $2.9B
Acelity said today that it inked a definitive agreement with Allergan (NYSE:AGN) to sell its LifeCell business for $2.9 billion in cash. The deal will put LifeCell’s regenerative medicine and reconstructive portfolio under Allergan’s roof, joining its medical aesthetics, breast implant and tissue expander product lines. Dublin-based Allergan said it expects will generate approximately $450 million in […]
MassDevice Network
@MassDevice
LinkedIn
Google+